Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion description "[When compared with their CD133? counterparts, CD133(+) cells not only possess the preferential ability to form undifferentiated tumor spheroids in vitro but also express an enhanced level of stem cell-associated genes, have a greater ability to form tumors when implanted orthotopically in immunodeficient mice, and can be serially passaged into secondary animal recipients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion evidence source_evidence_literature NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion SIO_000772 21112564 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion wasDerivedFrom befree-20140225 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion wasGeneratedBy ECO_0000203 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.